5/20/16 19:26 | 5/19/16 | AIQ | Health | Health | Medical Laboratories | Longmore-Grund Rhonda A | CA | O | EVP,CFO | P | 19 | 7.59 | 0 | 3 | New | 3 | D | -74 | -64 | 2 | 4 | 5 | 3 | 10 | -2 | 0 | -1 | -13 | -15 | 5 | |
5/19/16 19:13 | 5/17/16 | AIQ | Health | Health | Medical Laboratories | Tomlinson Percy C Jr | CA | DO | P,CEO | P | 23 | 7.61 | 0 | 3 | 30 | 13 | D | -74 | -64 | -5 | 4 | 7 | 4 | 14 | -5 | -1 | 1 | -15 | -17 | 4 | |
5/18/16 19:08 | 5/16/16 | AIQ | Health | Health | Medical Laboratories | Johns Richard W | CA | O | COO,CLO | P | 20 | 7.93 | 0 | 3 | New | 3 | D | -75 | -64 | -19 | 4 | 5 | 6 | 11 | 10 | -1 | -2 | -16 | -17 | 0 | |
5/16/16 20:54 | 5/10/16 | AIQ | Health | Health | Medical Laboratories | Spurlock Gregory E. | CA | O | P,Allian | P | 33 | 6.63 | 0 | 5 | New | 5 | D | -73 | -63 | -15 | 15 | 11 | 11 | 11 | 17 | 0 | -3 | -16 | -17 | -2 | |
5/13/16 15:58 | 5/13/16 | AIQ | Health | Health | Medical Laboratories | Tomlinson Percy C Jr | CA | DO | P,CEO | P | 15 | 7.34 | 0 | 2 | 25 | 10 | D | -77 | -67 | -29 | 5 | -3 | -3 | -3 | 4 | 15 | 8 | -6 | -10 | 8 | |
5/12/16 21:41 | 5/10/16 | AIQ | Health | Health | Medical Laboratories | Tomlinson Percy C Jr | CA | DO | P,CEO | P.m | 55 | 6.82 | 0 | 8 | New | 8 | D | -79 | -67 | -29 | 4 | -5 | -3 | -3 | 1 | 15 | 10 | -5 | -10 | 13 | |
8/15/11 21:33 | 8/15/11 | AIQ | Health | Health | Medical Laboratories | Buckelew Larry C. | CA | D | | P | 35 | 1.76 | 1 | 20 | 49 | 61 | D | -69 | -64 | -61 | -61 | -56 | -51 | -49 | 34 | -3 | -13 | -18 | -18 | -11 | |
8/12/11 17:47 | 8/10/11 | AIQ | Health | Health | Medical Laboratories | Samek Edward L | CA | D | | P | 56 | 1.12 | 1 | 50 | 79 | 114 | I | -70 | -65 | -62 | -63 | -58 | -55 | -51 | -43 | -5 | -16 | -25 | -25 | -18 | |
11/3/10 20:08 | 11/1/10 | AIQ | Health | Health | Medical Laboratories | Mts Health Investors Ii, LP | NY | T | | P | 1,483 | 3.96 | 1 | 375 | 2 | 25,079 | M | -45 | -17 | -17 | -3 | -2 | -3 | 4 | 17 | 0 | -3 | -18 | -4 | -6 | -73 |
11/3/10 20:06 | 11/1/10 | AIQ | Health | Health | Medical Laboratories | Ocm Principal Opportunities Fund Iv, LP | CA | T | | P | 1,483 | 3.96 | 1 | 375 | 2 | 25,079 | M | -45 | -17 | -17 | -3 | -2 | -3 | 4 | 17 | 0 | -3 | -18 | -4 | -6 | -73 |
11/3/10 20:05 | 11/1/10 | AIQ | Health | Health | Medical Laboratories | Lane Curtis | NY | DT | | P | 1,483 | 3.96 | 1 | 375 | 2 | 24,903 | I | -45 | -17 | -17 | -3 | -2 | -3 | 4 | 17 | 0 | -3 | -18 | -4 | -6 | -73 |
11/3/10 20:04 | 11/1/10 | AIQ | Health | Health | Medical Laboratories | Harmon Michael P | CA | DT | | P | 1,483 | 3.96 | 1 | 375 | 1 | 27,190 | I | -45 | -17 | -17 | -3 | -2 | -3 | 4 | 17 | 0 | -3 | -18 | -4 | -6 | -73 |
11/3/10 18:43 | 11/1/10 | AIQ | Health | Health | Medical Laboratories | Bendikson Aaron | CA | DT | | P | 1,483 | 3.96 | 1 | 375 | 1 | 27,190 | I | -45 | -17 | -17 | -3 | -2 | -3 | 4 | 17 | 0 | -3 | -18 | -4 | -6 | -73 |
11/1/10 15:59 | 10/29/10 | AIQ | Health | Health | Medical Laboratories | Mts Health Investors Ii, LP | NY | T | | P | 2,260 | 3.77 | 1 | 600 | 2 | 24,734 | M | -43 | -28 | -30 | -8 | -14 | -16 | -9 | -4 | 8 | 10 | -5 | 6 | 8 | -71 |
11/1/10 15:57 | 10/29/10 | AIQ | Health | Health | Medical Laboratories | Ocm Principal Opportunities Fund Iv, LP | CA | T | | P | 2,260 | 3.77 | 1 | 600 | 2 | 24,734 | M | -43 | -28 | -30 | -8 | -14 | -16 | -9 | -4 | 8 | 10 | -5 | 6 | 8 | -71 |
11/1/10 15:53 | 10/29/10 | AIQ | Health | Health | Medical Laboratories | Lane Curtis | NY | DT | | P | 2,260 | 3.77 | 1 | 600 | 3 | 24,561 | I | -43 | -28 | -30 | -8 | -14 | -16 | -9 | -4 | 8 | 10 | -5 | 6 | 8 | -71 |
11/1/10 15:49 | 10/29/10 | AIQ | Health | Health | Medical Laboratories | Harmon Michael P | CA | DT | | P | 2,260 | 3.77 | 1 | 600 | 2 | 26,815 | I | -43 | -28 | -30 | -8 | -14 | -16 | -9 | -4 | 8 | 10 | -5 | 6 | 8 | -71 |
11/1/10 15:46 | 10/29/10 | AIQ | Health | Health | Medical Laboratories | Bendikson Aaron | CA | DT | | P | 2,260 | 3.77 | 1 | 600 | 1 | 46,815 | I | -43 | -28 | -30 | -8 | -14 | -16 | -9 | -4 | 8 | 10 | -5 | 6 | 8 | -71 |
9/1/10 15:00 | 8/30/10 | AIQ | Health | Health | Medical Laboratories | Lane Curtis | NY | DT | | P | 84 | 3.88 | 1 | 22 | 0 | 24,183 | I | -64 | -24 | -14 | -23 | 12 | -6 | -10 | -4 | 4 | 4 | 9 | -11 | -3 | -64 |
9/1/10 14:57 | 8/30/10 | AIQ | Health | Health | Medical Laboratories | Mts Health Investors Ii, LP | NY | T | | P | 84 | 3.88 | 1 | 22 | 0 | 24,183 | I | -64 | -24 | -14 | -23 | 12 | -6 | -10 | -4 | 4 | 4 | 9 | -11 | -3 | -64 |
9/1/10 14:54 | 8/30/10 | AIQ | Health | Health | Medical Laboratories | Ocm Principal Opportunities Fund Iv, LP | CA | T | | P | 84 | 3.88 | 1 | 22 | 0 | 24,183 | I | -64 | -24 | -14 | -23 | 12 | -6 | -10 | -4 | 4 | 4 | 9 | -11 | -3 | -64 |
8/17/10 21:13 | 8/13/10 | AIQ | Health | Health | Medical Laboratories | Lane Curtis | NY | DT | | P.m | 675 | 4.50 | 1 | 150 | 1 | 24,013 | I | -59 | -11 | -6 | -19 | 28 | 23 | 3 | 4 | 1 | -1 | -6 | -11 | -11 | -66 |
8/17/10 21:11 | 8/13/10 | AIQ | Health | Health | Medical Laboratories | Harmon Michael P | CA | DT | | P.m | 675 | 4.50 | 1 | 150 | 1 | 26,169 | I | -59 | -11 | -6 | -19 | 28 | 23 | 3 | 4 | 1 | -1 | -6 | -11 | -11 | -66 |
8/17/10 21:10 | 8/13/10 | AIQ | Health | Health | Medical Laboratories | Bendikson Aaron | CA | DT | | P.m | 675 | 4.50 | 1 | 150 | 1 | 26,169 | I | -59 | -11 | -6 | -19 | 28 | 23 | 3 | 4 | 1 | -1 | -6 | -11 | -11 | -66 |
8/17/10 21:08 | 8/13/10 | AIQ | Health | Health | Medical Laboratories | Mts Health Investors Ii, LP | NY | T | | P.m | 675 | 4.50 | 1 | 150 | 1 | 24,175 | M | -59 | -11 | -6 | -19 | 28 | 23 | 3 | 4 | 1 | -1 | -6 | -11 | -11 | -66 |
8/17/10 21:07 | 8/13/10 | AIQ | Health | Health | Medical Laboratories | Ocm Principal Opportunities Fund Iv, LP | CA | T | | P.m | 675 | 4.50 | 1 | 150 | 1 | 24,175 | M | -59 | -11 | -6 | -19 | 28 | 23 | 3 | 4 | 1 | -1 | -6 | -11 | -11 | -66 |
8/9/10 10:21 | 8/6/10 | AIQ | Health | Health | Medical Laboratories | Viviano Paul S | CA | DO | CB,CEO | P | 45 | 4.48 | 1 | 10 | 2 | 574 | D | -56 | -10 | -2 | -4 | 4 | 23 | 30 | 5 | 3 | -3 | -8 | -7 | -9 | -34 |
8/9/10 10:09 | 7/30/10 | AIQ | Health | Health | Medical Laboratories | Samek Edward L | CA | D | | P.a | 41 | 4.14 | 1 | 10 | 30 | 43 | D | -56 | -10 | -2 | -4 | 4 | 23 | 30 | 5 | 3 | -3 | -8 | -7 | -9 | -34 |
8/5/10 16:27 | 8/3/10 | AIQ | Health | Health | Medical Laboratories | Mts Health Investors Ii, LP | NY | T | | P | 207 | 4.25 | 1 | 49 | 0 | 26,065 | M | -55 | -14 | -9 | -15 | -2 | 10 | 16 | 10 | 4 | -1 | -2 | -2 | -7 | -27 |
8/5/10 16:26 | 8/3/10 | AIQ | Health | Health | Medical Laboratories | Ocm Principal Opportunities Fund Iv, LP | CA | T | | P | 207 | 4.25 | 1 | 49 | 0 | 26,065 | M | -55 | -14 | -9 | -15 | -2 | 10 | 16 | 10 | 4 | -1 | -2 | -2 | -7 | -27 |
8/5/10 16:25 | 8/3/10 | AIQ | Health | Health | Medical Laboratories | Lane Curtis | NY | DT | | P | 207 | 4.25 | 1 | 49 | 0 | 24,356 | I | -55 | -14 | -9 | -15 | -2 | 10 | 16 | 10 | 4 | -1 | -2 | -2 | -7 | -27 |
8/5/10 16:25 | 8/3/10 | AIQ | Health | Health | Medical Laboratories | Harmon Michael P | CA | DT | | P | 207 | 4.25 | 1 | 49 | 0 | 26,065 | I | -55 | -14 | -9 | -15 | -2 | 10 | 16 | 10 | 4 | -1 | -2 | -2 | -7 | -27 |
8/5/10 16:24 | 8/3/10 | AIQ | Health | Health | Medical Laboratories | Bendikson Aaron | CA | DT | | P | 207 | 4.25 | 1 | 49 | 0 | 26,065 | I | -55 | -14 | -9 | -15 | -2 | 10 | 16 | 10 | 4 | -1 | -2 | -2 | -7 | -27 |
8/3/10 20:52 | 7/30/10 | AIQ | Health | Health | Medical Laboratories | Mts Health Investors Ii, LP | NY | T | | P.m | 4,687 | 3.95 | 1 | 1,187 | 5 | 26,016 | M | -55 | -14 | -15 | -25 | -13 | 7 | 11 | 18 | 3 | 9 | -6 | -12 | -7 | -25 |
8/3/10 20:50 | 7/30/10 | AIQ | Health | Health | Medical Laboratories | Ocm Principal Opportunities Fund Iv, LP | CA | T | | P.m | 4,687 | 3.95 | 1 | 1,187 | 5 | 26,016 | M | -55 | -14 | -15 | -25 | -13 | 7 | 11 | 18 | 3 | 9 | -6 | -12 | -7 | -25 |
8/3/10 20:47 | 7/30/10 | AIQ | Health | Health | Medical Laboratories | Lane Curtis | NY | DT | | P.m | 4,687 | 3.95 | 1 | 1,187 | 5 | 24,312 | I | -55 | -14 | -15 | -25 | -13 | 7 | 11 | 18 | 3 | 9 | -6 | -12 | -7 | -25 |
8/3/10 20:45 | 7/30/10 | AIQ | Health | Health | Medical Laboratories | Harmon Michael P | CA | DT | | P.m | 4,687 | 3.95 | 1 | 1,187 | 5 | 26,016 | I | -55 | -14 | -15 | -25 | -13 | 7 | 11 | 18 | 3 | 9 | -6 | -12 | -7 | -25 |
8/3/10 20:44 | 7/30/10 | AIQ | Health | Health | Medical Laboratories | Bendikson Aaron | CA | DT | | P.m | 4,687 | 3.95 | 1 | 1,187 | 5 | 26,016 | I | -55 | -14 | -15 | -25 | -13 | 7 | 11 | 18 | 3 | 9 | -6 | -12 | -7 | -25 |
11/5/04 17:27 | 11/4/04 | AIQ | Health | Health | Medical Laboratories | Hanson R Brian | CA | O | EVP,CFO | P | 50 | 7.14 | 1 | 7 | 59 | 19 | D | -34 | 71 | 80 | 44 | -7 | 13 | -6 | -6 | 8 | 9 | 40 | 71 | 52 | -6 |